References | 1. Maughan, R.J.; Burke, L.M.; Dvorak, J.; Larson-Meyer, D.E.; Peeling, P.; Phillips, S.M.; Rawson, E.S.; Walsh, N.P.; Garthe, I.; Geyer, H.; et al. IOC consensus statement: Dietary supplements and the high-performance athlete. Br. J. Sports Med. 2018, 52, 439–455. https://doi.org/10.1136/bjsports-2018-099027. 2. Burke, L.M.; Peeling, P. Methodologies for investigating performance changes with supplement use. Int. J. Sport Nutr. Exerc. Metab. 2018, 28, 159–169. https://doi.org/10.1123/ijsnem.2017-0325. 3. Garthe, I.; Maughan, R.J. Athletes and supplements: Prevalence and perspectives. Int. J. Sport Nutr. Exerc. Metab. 2018, 28, 126–138. https://doi.org/10.1123/ijsnem.2017-0429. 4. Knapik, J.J.; Steelman, R.A.; Hoedebecke, S.S.; Austin, K.G.; Farina, E.K.; Lieberman, H.R. Prevalence of dietary supplement use by athletes: Systematic review and meta-analysis. Sports Med. 2016, 46, 103–123. https://doi.org/10.1007/s40279-015-0387-7. 5. Catalani, V.; Negri, A.; Townshend, H.; Simonato, P.; Prilutskaya, M.; Tippett, A.; Corazza, O. The market of sport supplement in the digital era: A netnographic analysis of perceived risks, side-effects and other safety issues. Emerg. Trends Drugs Addict. Health 2021, 1, 100014. https://doi.org/10.1016/j.etdah.2021.100014. 6. Chauhan, E.S.; Chaudhary, M.; Singh, R. Effects of ergogenic supplements and dietary supplements on young athletes’ performance: A review. Sci. J. Sport Perform. 2022, 1, 71–82. https://doi.org/10.55860/VZJN9038. 7. Mettler, S.; Lehner, G.; Morgan, G. Widespread supplement intake and use of poor quality information in elite adolescent Swiss athletes. Int. J. Sport Nutr. Exerc. Metab. 2021, 22, 1–8. https://doi.org/10.1123/ijsnem.2021-0043. 8. Wang, Z.; Qiu, B.; Li, R.; Han, Y.; Petersen, C.; Liu, S.; Zhang, Y.; Liu, C.; Candow, D.G.; Del Coso, J. Effects of creatine supplementation and resistance training on muscle strength gains in adults < 50 years of age: A systematic review and me-ta-analysis. Nutrients 2024, 16, 3665. https://doi.org/10.3390/nu16213665. 9. Hurst, P.; Schiphof-Godart, L.; Kavussanu, M.; Barkoukis, V.; Petróczi, A.; Ring, C. Are dietary supplement users more likely to dope than non-users? A systematic review and meta-analysis. Int. J. Drug Policy 2023, 117, 104077. https://doi.org/10.1016/j.drugpo.2023.104077. 10. Backhouse, S.H.; Whitaker, L.; Petróczi, A. Gateway to doping? Supplement use in the context of preferred competitive situations, doping attitude, beliefs, and norms. Scand. J. Med. Sci. Sports 2013, 23, 244–252. https://doi.org/10.1111/j.1600-0838.2011.01374.x. 11. Barkoukis, V.; Lazuras, L.; Ourda, D.; Tsorbatzoudis, H. Are nutritional supplements a gateway to doping use in competitive team sports? The roles of achievement goals and motivational regulations. J. Sci. Med. Sport 2020, 23, 625–632. https://doi.org/10.1016/j.jsams.2019.12.021. 12. Heller, S.; Ulruch, R.; Simon, P.; Dietz, P. Refined analysis of a cross-sectional doping survey among recreational triathletes: Support for the nutritional supplement gateway hypothesis. Front. Psychol. 2020, 23, 561013. https://doi.org/10.3389/fpsyg.2020.561013. 13. Barkoukis, V.; Lazuras, L.; Lucidi, F.; Tsorbatzoudis, H. Nutritional supplement and doping use in sport: Possible underlying social cognitive processes. Scand. J. Med. Sci. Sports 2015, 25, 582–588. https://doi.org/10.1111/sms.12377. 14. Dietz, P.; Ulrich, R.; Dalaker, R.; Striegel, H.; Franke, A.G.; Lieb, K.; Simon, P. Associations between physical and cognitive doping—A cross-sectional study in 2997 triathletes. PLoS ONE 2013, 8, e78702. https://doi.org/10.1371/journal.pone.0078702. 15. Kandel, D.B. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis, 1st ed.; Cambridge University Press: Cambridge, UK, 2002. https://doi.org/10.1017/CBO9780511499777. 16. Karazsia, B.T.; Crowther, J.H.; Galiotom, R. Undergraduate men’s use of performance- and appearance-enhancing substances: An examination of the gateway hypothesis. Psychol. Men Masculinity 2013, 14, 129–137. https://doi.org/10.1037/a0027810. 17. Lentillon-Kaestner, V.; Carstairs, C. Doping use among young elite cyclists: A qualitative psychosociological approach. Scand. J. Med. Sci. Sports 2010, 20, 336–345. https://doi.org/10.1111/j.1600-0838.2009.00885.x. 18. Hurst, P.; Foad, A.; Coleman, D.; Beedie, C. Development and validation of the Sports Supplements Belief Scale. Perform. Enhanc. Health 2017, 5, 89–97. https://doi.org/10.1016/j.peh.2016.10.001. 19. Bloodworth, A.J.; Petróczi, A.; Bailey, R.; Pearce, G.; McNamee, M.J. Doping and supplementation: The attitudes of talented young athletes. Scand. J. Med. Sci. Sports 2012, 22, 293–301. https://doi.org/10.1111/j.1600-0838.2010.01239.x. 20. Hurst, P.; Kavussanu, M.; Boardley, I.; Ring, C. Sport supplement use predicts doping attitudes and likelihood via sport supplement beliefs. J. Sports Sci. 2019, 37, 1734–1740. https://doi.org/10.1080/02640414.2019.1589920. 21. Hurst, P.; Ring, C.; Kavussanu, M. Athletes using ergogenic and medical sport supplements report more favourable attitudes to doping than non-users. J. Sci. Med. Sport 2021, 24, 307–311. https://doi.org/10.1016/j.jsams.2020.09.012. 22. Hurst, P.; Ring, C.; Kavussanu, M. Ego orientation is related to doping likelihood via sport supplement use and sport sup-plement beliefs. Eur. J. Sport Sci. 2022. https://doi.org/10.1080/17461391.2021.1995509. 23. Australian Institute of Sport (AIS). The AIS Sport Supplement Framework. AIS: 2019. Available online: https://www.ais.gov.au/nutrition/supplements (accessed on 6 October 2020). 24. Hildebrandt, T.; Harty, S.; Langenbucher, J.W. Fitness supplements as a gateway substance for anabolic-androgenic steroid use. Psychol. Addict. Behav. 2012, 26, 955–962. https://doi.org/10.1037/a0027877. 25. Ntoumanis, N.; Dølven, S.; Barkoukis, V.; Boardley, I.D.; Hvidemose, J.S.; Juhl, C.B.; Gucciardi, D.F. Psychosocial predictors of doping intentions and use in sport and exercise: A systematic review and meta-analysis. British Journal of Sports Medicine 2024. https://doi.org/10.1136/bjsports-2023-107910. 26. Donovan, R.J.; Jalleh, G.; Gucciardi, D. Research Package for Anti-Doping Organizations. WADA. 2015. Available online: https://www.wada-ama.org/sites/default/files/resources/files/wada_so... (accessed on 6 October 2020). 27. Ring, C.; Kavussanu, M.; Lucidi, S.; Hurst, P. Effects of personal and situational factors on self-referenced doping likelihood. Psychol. Sport Exerc. 2019, 41, 29–35. https://doi.org/10.1016/j.psychsport.2018.11.003. 28. Faul, F.; Erdfelder, E.; Lang, A.-G.; Buchner, A. G*Power 3: A flexible statistical power analysis program for the social, be-havioral, and biomedical sciences. Behav. Res. Methods 2007, 39, 175–191. https://doi.org/10.3758/BF03193146. 29. Cohen, J. A power primer. Psychol. Bull. 1992, 112, 155–159. https://doi.org/10.1037/0033-2909.112.1.155. 30. Cronbach, L.J. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16, 297–334. https://doi.org/10.1007/BF02310555. 31. Hayes, A.F. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach; Guilford Press: New York, NY, USA, 2013. 32. WADA. The World Anti-Doping Code; The World Anti-Doping Agency: Montreal, Canada, 2021. Available online: https://www.wada-ama.org/sites/default/files/resources/files/2021_wa... (accessed on 6 October 2020). 33. Gleaves, J.; Petróczi, A.; Folkerts, D.; De Hon, O.; Macedo, E.; Saugy, M.; Cruyff, M. Doping prevalence in competitive sport: Evidence synthesis with “best practice” recommendations and reporting guidelines from the WADA working group on doping prevalence. Sports Med. 2021, 51, 1909–1934. https://doi.org/10.1007/s40279-021-01477-y. 34. WADA. 2019 Anti-Doping Testing Figures; WADA: Montreal, Canada, 2019. Available online: https://www.wada-ama.org/sites/default/files/resources/files/2019_an... (accessed on 6 Oc-tober 2020). |
---|